drugset
drugset / Trial / NCT00948506

Trial of Topical Cidofovir for the Prevention of Hair Growth

NCT00948506 ↗

Phase 2 Completed 20 enrolled University of Pennsylvania
RandomizedParallel-groupDouble-blindPrevention

Summary

This is a two-arm, single center placebo-controlled double-blind proof of concept study which will evaluate the safety and efficacy of topical cidofovir (both 1% and 3%)compared to placebo for the prevention of hair growth.

Timeline

Start
2009-07
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator CIDOFOVIR ANHYDROUS Small molecule 1 % Topical
Comparator CIDOFOVIR ANHYDROUS Small molecule 3 % Topical

Indications

No indication recorded.